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TNFa GENE TARGETING VIA TRIPLE-HELIX FORMATION: COULD AN
ANTI-GENE STRATEGY BE AN ALTERNATIVE TO ANTI TNF ANTIBODIES
FOR ARTHRITIS?
L. Grossin, Jr., J. Paquet, Jr., C. Henrionnet, Jr., A. Pinzano, Jr., D. Loeuille,
Sr., P. Netter, Sr., P. Gillet, Sr.. UMR7561 CNRS, Vandoeuvre les nancy, France
Purpose:We investigated if an anti-TNF-a triplex-forming oligonucleotide
(TFO), employed as anti-gene strategy, could be an alternative to antisense
technology in silencing TNF-a activation during articular inﬂammation. In
this study, we analyzed in vitro and in vivo anti-inﬂammatory potentiali-
ties of an anti-TNF-a TFO, as judged from effects on two rat arthritis
models.
Methods: The inhibitory activity of this TFO on articular cells stimulated by
IL-1ß (synoviocytes and chondrocytes) was assessed and compared to that
of small interfering RNA (siRNA) in vitro, at mRNA expression levels by
real-time RT-PCR, as well as at proteins level (TNF-a & NO release). In vivo,
the biological effects of a preventive intraarticular injection of such an
oligonucleotide were ﬁrst investigated in an acute arthritis model, by the
follow-up of clinical (body weight, pain, joint swelling), biochemical
(anabolism loss, cytokines levels) and histological (synovium, cartilage,and
bone) parameters. We then conﬁrmed the efﬁciency of a preventive ia
injection of anti-TNF-a TFO in an immunological experimental chronic
arthritis model, according to similar parameters (clinical, biochemical and
histological assessments).
Results: In vitro, we have demonstrated that a TFO designed to target
TNF-a promoter was able to inhibit mRNA expression (86%) and to prevent
TNF-a release into supernatants (62%) as well as NO release (80%). The
inhibition rate, at mRNA level, was similar to the one observed with TNF-
a speciﬁc siRNA, the main advantage of TFO being the concentration used
(1nM vs 75 nM for siRNA). A differencewas observed at proteins level, with
approximatively a 20% more efﬁcient inhibition with TFO, compared to
siRNA.
The use of the anti-TNF-a TFO as a preventive and local treatment in both
acute and chronic arthritis models signiﬁcantly reduced diseasedevelopment. In the acute inﬂammatory model, the TFO provided
a stronger inhibition than the siRNA, with a long lasting biological effect,
conﬁrmed by histological assessement. In the immunological RA model,
we have demonstrated that a preventive ia injection of the TFO lead to
a signiﬁcant correction of body weight distribution (incapacitancy test),
conﬁrmed by the histological grading of the knees. Indeed, ﬁbrosis and
inﬁltration were signiﬁcantly decreased compraed to arthritic rats. Anal-
ysis of synovial ﬂuid has demonstrated a signiﬁcant decrease of inﬂam-
matory mediators like cytokines (TNF-a, IL-1ß, IL-2, IL-5) and chemokines
(MCP1, MIP-1a) in animals preventively treated with TFO compared to
naives. Furthermore, the TFO efﬁciently blocked synovitis and cartilage
and bone destruction in the joints.
Conclusions: We showed the effectiveness of siRNA and TFO in modu-
lating both in vitro and in vivo inﬂammatory processes. Interestingly,
silencing was increased with TFO, enabling improved protection of artic-
ular components. We extended our ﬁndings by demonstrating for the ﬁrst
time that in rats developing arthritis, a preventive injection of anti-TNF-
aTFO led to local and systemic TNF-a inhibition associated with
improvement of ancillary clinical signs of arthritis. The results presented
here provide the ﬁrst evidence that gene targeting by anti-TNF-a TFO
modulates arthritis in vivo, thus providing proof-of-concept that it could
be used as therapeutic tool for TNF-a-dependent inﬂammatory disorders.
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SUSTAINED REGULATION OF INFLAMMATION IN CHONDROCYTES BY
BIOMECHANICAL SIGNALS VIA THE JAK3-STAT3 PATHWAY
J. Nam1, P. Perera 2, B. Rath 3, S. Agarwal 2. 1Univ. of California, Riverside, CA,
USA; 2 The Ohio State Univ., Columbus, OH, USA; 3Univ. of Aachen, Aachen,
Germany
Purpose: Exercise is essential for maintaining cartilage health and thera-
peutic for degenerating cartilage during the progression of early osteoar-
thritis (OA) as shown in our animal models. At themolecular level, we have
also shown that physiological magnitudes of mechanical forces are anti-
inﬂammatory and suppress the transcriptional activities of nuclear tran-
scription factor kappaB (NF-kB) by intercepting NF-kB signaling cascades.
In this study, we examined the role of IL-11 via JAK3-STAT3-SOCS3
signaling cascade in inducing sustained anti-inﬂammatory state by phys-
iological magnitudes of dynamic compressive strain (DCS). These ﬁndings
further correlate with the attenuation of pro-inﬂammatory genes during
the progression of OA by exercise in an animal model.
Methods: OSU Institutional Animal and Care Committee preapproved all
protocols. Rat chondrocytes (5 x 105 cells/scaffold) were inoculated on 3D
6x3 mm cylindrical scaffolds fabricated by electrospinning of poly(ε-cap-
rolactone), 6 days prior to experimentation. Subsequently, the constructs
were subjected to various conditions: 1) untreated control, 2) IL-1b (1 ng/
ml), 3) DCS alone (10% cyclic strain at 1 Hz), or 4) IL-1b and DCS for various
durations. The effects of DCS on the overall gene expressionwere analyzed
by Affymetrix Rat GeneChip 1.0 ST microarrays and the results conﬁrmed
by real time PCR using custom designed primers for IL-11 and SOCS3.
Activation of the JAK-STAT pathway was examined via phosphorylation of
JAK1, -2, -3, and phosphorylation of STAT3, -5, and IL-11 protein expression
by Western blot analysis (WBA). To investigate the relationship between
IL-11 and JAK-STAT activation, IL-11 was knocked down by siRNA. All
experiments were performed at least in triplicate and statistical signiﬁ-
cance calculated by ANOVA with Tukey's post-hoc. Results: Microarray
gene expression analysis on the ACs subjected to IL-1b (1 ng/ml) alone or
10% DCS in the presence of IL-1b revealed that 1163 genes out of approx-
imately 27000 genes (detectable by GeneChip) were signiﬁcantly regu-
lated more than 2 fold as compared to untreated controls. Speciﬁcally,
most of the genes that were upregulated by IL-1b and drastically down-
regulated by DCS, were related to inﬂammation including Ccl20, Nos2a,
Cxcl2, Ccl7, Cx3cl1, Tnf, Cxcl6, Lcn2, Il23a, and Tnfaip2, known to be under
the control of the NF-kB pathway. On the other hand, IL-11 and its tran-
scriptional regulators (Fosb, Fos, Jun, Jund, and Atf3) were signiﬁcantly
upregulated by DCS in the presence of IL-1b. The WBA revealed that JAK3
and STAT3 are activated by DCS regardless of the presence of IL-1b. The
interference of DCS-induced IL-11 synthesis by IL-11 siRNA resulted in the
inhibition of STAT3 activation, likely indicating that DCS induces the JAK3-
STAT3 phosphorylation via IL-11 induction. The activation of STAT3, in
